Rigel Pharmaceuticals Inc.

Recent Events

News & Analysis

biotech and rigel pharmaceuticals inc. - All News and Analysis

• Rigel Pharma: The Importance of Knowing Your Stock

  Seeking Alpha - 2009-07-29

  Stone Fox Capital submits: Last Thursday night, Rigel Pharma RIGL released disappointing results on its TASKi3 Phase 2b study on Rheumatoid Arthritis (RA). The results showed that the placebo worked basically as well as the R788 pill. Now here is where you need to understand the stock and what was...

  Tags: Biotech, Healthcare, Stone Fox Capital, Rigel Pharmaceuticals Inc.

• Rigel Pharmaceuticals: A Game Changer in the Works?

  Seeking Alpha - 2009-06-28

  Dr. Anthony submits: With the impending announcement of the Phase IIb data for Rigel's RIGL lead compound R-788, I thought I would share my analysis. Rheumatoid Arthritis is a chronic debilitating disease that requires life-long treatment, which makes it a lucrative market but also at the same time very competitive....

  Tags: Biotech, Dr. Anthony, Rigel Pharmaceuticals Inc.

• Rigel and Seattle Genetics: The Delicate Art of Expectation Management

  Seeking Alpha - 2009-02-09

  Ohad Hammer submits: In my previous article, I discussed the pharmaceutical industry’s race after approved drugs and late stage agents with proof of concept in humans. I mentioned Rigel’s RIGL lead drug, R788, as a likely target for collaboration due to its impressive activity, the huge addressable market and the...

  Tags: Biotech, Ohad Hammer, Rigel Pharmaceuticals Inc., Seattle Genetics Inc.

• Rigel Still on Track, And Has Pfizer Found Its Next Blockbuster?

  Seeking Alpha - 2009-01-08

  Ohad Hammer submits: In the pharmaceutical industry, 2008 will probably be marked by the big pharmas’ insatiable appetite for new drugs. Threatened by fierce generic competition, the pharmaceutical giants were not only eager to pay generous acquisition premiums for marketed products, but were also willing to pay a lot of...

  Tags: Biotech, Healthcare, Ohad Hammer, Pfizer Inc., Rigel Pharmaceuticals Inc.

• Rigel's Punishment May Prove Short-Sighted

  Seeking Alpha - 2008-10-31

  EP Vantage submits: Rigel Pharmceuticals' RIGL shares have lost almost half their value this week since the release of fresh data from a phase II study of its lead product, R788 in rheumatoid arthritis, which considering the new information was neither overwhelmingly negative, nor entirely new, seems an overly severe...

  Tags: Seeking Alpha, Rigel, EP Vantage, Sales Strategy, Sales, Rigel Pharmaceuticals Inc., Biotech, Healthcare

• My Model Biotech Picks: What's Hot and What's Not

  Seeking Alpha - 2008-08-13

  A. Reza Saadat submits: Analyzing the performance of my previous picks is by far my favorite part of writing this blog. It has on many occasions allowed be to learn from my mistakes.I have moved the numbers to Google docs so that they are easier to read. Here is...

  Tags: Biotech, Alnylam Pharmaceuticals Inc., Amgen Inc., Amylin Pharmaceuticals Inc., Celgene Corp., Rigel Pharmaceuticals Inc., Seattle Genetics Inc.